Avon Products, Inc.

The derivative action brought on behalf of Avon and its shareholders alleges breach of fiduciary duty claims against certain officers and directors in connection with, among other things, alleged violations of the Foreign Corrupt Practices Act of 1977 (“FCPA”). It is alleged that Avon violated the FCPA by paying bribes and kickbacks to get or…

Galena Biopharma, Inc.

The derivative action brought on behalf of Galena and its shareholders arises from allegations that certain officers and/or directors of Galena secretly hired a stock promotion firm to “pump up” Galena’s stock price, so that they could later sell Galena stock while in possession of non-public information and at a time when Galena stock was…

Maxwell Technologies, Inc.

Maxwell was alleged to have lacked the internal controls necessary to prevent improper revenue recognition and to have falsely represented its operations and finances between April 28, 2011 and 2013. Hynes Keller & Hernandez was an integral part of a team of attorneys that caused Maxwell to adopt corporate governance reforms that not only strengthened…

Accretive Health Inc.

Accretive Health Inc. (“Accretive” or the “Company”), a registered debt-collection agency in Minnesota and several other states, was alleged to have violated numerous debt collection statutes and patient privacy laws in connection with the operation of its business. These violations became public when the Minnesota Attorney General’s Office filed a lawsuit against the Company in…

Skechers USA, Inc.

Skechers USA, Inc. (“Skechers” or the “Company”) was accused of using numerous “unfounded claims” in the advertising of its “Shape-ups” line of rocker-bottom shoes. These “unfounded claims” resulted in numerous consumer and personal injury lawsuits and a $40 million settlement with the Federal Trade Commission. Through the diligence of Hynes Keller & Hernandez, and after…